Case Report introduCtion Acute generalized exanthematous pustulosis (AGEP) is a severe cutaneous adverse reaction (SCAR), mostly induced by systemic drugs (90%), characterized by an acute-onset, sterile, pustular eruption starting from flexural areas and soon becoming generalized. [1, 2] Case reports of AGEP associated with herbal medications remain rare but have increased in the past decade. However, most of them were not confirmed by patch testing. [3] [4] [5] [6] [7] [8] [9] Herein, we report a case of AGEP induced by Radix Aucklandiae (dried root of Saussurea costus) with a definite RegiSCAR validation score and confirmed by patch testing including a series of most commonly used crude drugs in traditional Chinese medications (TCMs) in Taiwan. To our knowledge, this is the first case report of AGEP associated with Radix Aucklandiae.
and scattered eosinophils in the dermis [ Figure 1d ]. Blood test revealed leukocytosis (10.51 k/µL) with neutrophil count 7115/µL and no systemic organ involvement. The typical morphology and distribution, clinical course, and skin pathology fulfilled the diagnosis of AGEP with a total RegiSCAR validation score of 8 (definite case). All lesions subsided with some typical postpusular pinpoint desquamation within 12 days. Patch tests were performed 4 weeks after complete remission of the symptoms, including a screening series of 27 most commonly used crude drugs in TCM ( , acetaminophen, amoxicillin trihydrate, mercury, and mercury (II) amidochloride (ammoniated mercury). The screening series of 27 most commonly used crude drugs in TCM were patch tested as 10% ethanol extracts, while acetaminophen and amoxicillin trihydrate were patch tested as 10% in petrolatum and mercury and ammoniated mercury as 0.5% and 1.0% in petrolatum, respectively (Chemotechnique Diagnostics, Vellinge, Sweden). The patient was patch tested on the back using IQ Chamber ® (from Chemotechnique Diagnostics AB, Vellinge, Sweden) and secured with 3M tape. The patch test material was removed after 48 h. Reading of the test was performed 72 h after the test application. The results showed only a positive reaction (+ according to the International Contact Dermatitis Research Group scoring recommendations) to Radix Aucklandiae and the other tested allergens were all negative. disCussion AGEP is a rare, sterile inflammation of the skin, frequently associated with fever, massive neutrophilia, and mostly induced by systemic drugs (90% of the cases), especially antimicrobial agents, or sometimes by acute viral infections. [1, 2] AGEP is clinically characterized by an acute onset of nonfollicular sterile pustules on an edematous erythema, beginning from the face or intertriginous areas, quickly expanding to the trunk and limbs within a few hours, and spontaneously resolved on drug withdrawal within 2 weeks. [2] Histopathological features of AGEP include spongiform subcorneal and/or intraepidermal pustules, papillary edema, polymorphous perivascular infiltrates with neutrophils, and occasionally leukocytoclastic vasculitis, but without psoriatic acanthosis or papillomatosis. [1] Cases of AGEP in Taiwan have been shown with a higher female predominance (68.7%), high level of C-reactive protein level, normal eosinophil count in most patients, and a fossae, bilateral flanks, and inner thighs [ Figure 1a- Saposhnikoviae). Furthermore, she had also taken amoxicillin and acetaminophen for a 2-day duration, discontinued 6 days before the eruption. Skin biopsy from the pustular lesion on the left arm showed extensive subcorneal pustules, spongiosis and neutrophilic exocytosis in the epidermis, papillary dermal edema, perivascular and interstitial infiltration of lymphocytes, many neutrophils, relatively low association with systemic drugs (62.5%), with older patients showing a stronger etiologic association with a previous sensitization by culprit drugs such as antibiotics. [10] There is a considerable popularity of using ethnic herbal medications in Asian populations, especially the use of TCM in Taiwan. Herbal medications can cause various adverse reactions in the dermatologic field, including allergic skin reactions, photosensitization, pellagra, arsenic dermatoses, mercury poisoning, and angioneurotic edema. [11] SCARs associated with herbal medications, such as Stevens-Johnson syndrome (SJS), drug hypersensitivity syndrome, and AGEP have also been occasionally documented. [3, 11, 12] In the past decade, the association of AGEP with different kinds of herbal medications has been increasingly identified, mostly in Asian countries. These are mainly single case reports from other countries [ Table 1 ]. [3] [4] [5] [6] [7] [8] [9] The culprit herbal agents included Gingko biloba, [4] velvet antler, [7] oral essential oil of Pistacia lentiscus, [8] and Pantax notoginseng saponins injection, [9] while other culprits were not identified [cases 1, 3, 4, 5, 6, and 7 in Table 1 ]. The onset of AGEP after drug exposure usually occurs within 48 h but varies between different medications, with an even shorter latent period (median treatment duration: 1 day) for antibiotics including sulfonamides, while a longer median onset time (11 days) was found with other associated drugs. [13] Similarly, the time period from the intake of associated herbal medications to the onset of AGEP also ranges from 1 day to 1 week in the previous reports.
[ [3] [4] [5] [6] [7] [8] [9] The currently reported case showed a slightly longer latent period of 2 weeks, but it is still reasonable. Theoretically, it usually takes longer time (7-21 days) to be sensitized when the participants do not have previous exposure to the allergens; if the participants have been sensitized to a certain allergen, it usually takes 1-2 days to elicit the allergic reactions. All the AGEP cases induced by herbal medications in the literature and in our case showed compatible histopathological features, benign clinical course, and if recorded definite RegiSCAR validation scores.
The usefulness and sensitivity of drug patch tests vary with the types of drug eruptions (more sensitive in AGEP, systemic contact dermatitis, fixed drug eruption, lichenoid, and maculopapular eruption) and also depend on the culprit drugs in each type of eruption (higher positive rates in patients patch tested with diltiazem, abacavir, β-lactam antibiotics, anticonvulsants, tetrazepam, and pseudoephedrine). [14, 15] The proportion of relevant positive patch tests has been shown significantly higher in AGEP (50%) than in other SCARs (26%), such as SJS or toxic epidermal necrolysis (TEN) (9%). [16] However, a more recent study to determine the value of drug patch test for the three main classes of SCARs showed a lower positivity rate in AGEP (58%) than in drug rash with eosinophilia and systemic symptoms (64%) but still higher than in SJS/TEN (24%). [17] Thus, patch test has become widely recognized as of value in the diagnosis of AGEP, narrowing differential diagnosis of ambiguous cases, and help in the identification of culprit agent. [1, 2] However, drug patch test has been rarely performed in the diagnosis of herbal medication-induced AGEP (except for a case induced by velvet antler) [7] nor has its relevant sensitivity been analyzed.
S. costus is a medicinal plant commonly used in the indigenous medical system in India, Tibet, Korea, and China. [18] In TCM, Radix Aucklandiae is derived from the dried root of S. costus and has the Chinese name Yun Mu Xiang. [19] Its several bioactive components have been observed as having anti-inflammatory, anticancer, hepatoprotective, antiulcer, cholagogic, immunomodulating, antimicrobial effects through different mechanisms (including the inhibitory effect on tumor necrosis factor-α and interferon-γ-induced chemokine production, inhibition on NF-kappa B pathway, and the anticomplementary activity). [18, 20, 21] Thus, S. costus has been commonly used in treating inflammation of the lungs (including chronic bronchitis and asthma), ulcer, abdominal pain, anorexia, nausea, rheumatism, and other conditions. [18, 21] Extracts of S. costus have also been reported to alleviate inflammatory chemokine production in vitro in human keratinocyte HaCaT cells and in vivo in-house dust mite-induced atopic-like dermatitis mouse model. [22] Despite several studies showing the anti-allergic effect of S. costus, [21, 22] it is also a well-known contact allergen with related haptens such as sesquiterpene lactones (including costunolide and dehydrocostuslactone), [19, 23] which have been paradoxically reported to inhibit antigen-induced degranulation with different potency in both in vivo and in vitro experiments of the asthma animal model. [21] In patients diagnosed as having allergic contact dermatitis (ACD) from TCM, Radix Aucklandiae yielded four positive reactions in 27 patients. [19] Sesquiterpene lactones (component of Radix Aucklandiae) was also suggested, along with colophonium and other nine Chinese medicinal crude drugs (Flos Caryophylli, Radix Angelicae Pubescentis, Cortex Cinnamomi, Cortex Radix Acanthopanacis, Caulis Impatientis, Resina Draconis/Sanguis Draconis, Fructus Cnidii, Radix Gentianae Macrophyllae, and Rhizoma Ligustici Chuanxiong), to be used as a screening patch test series in highly suspected cases of ACD from TCM. [19] However, the active causative ingredient of orally taken Radix Aucklandiae and its underlying mechanism involved in inducing AGEP remain unknown. The possible effects of other unknown adulterants in the TCM are also possible, giving the prevalence of adulteration as 23.7% in one Taiwanese study involving TCM associated with adverse effects and poisoning. [23] Mercury exposure has been reported as a culprit of AGEP. [24, 25] To exclude the possible adulteration of mercury in TCM leading to the development of AGEP, we performed patch testing with mercury and ammoniated mercury, and both were negative.
ConClusion
TCM as one of the culprits of AGEP should not be overlooked. A detailed investigation of herbal drug history is necessary. 
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